FDA Approves Axis-Shield and Bio-Rad's Diagnostic for RA - Genetic Engineering News

Genetic Engineering News

FDA Approves Axis-Shield and Bio-Rad's Diagnostic for RA Genetic Engineering News Axis-Shield and Bio-Rad Laboratories received FDA clearance of the BioPlex® 2200 Anti-CCP test for the detection of rheumatoid arthritis (RA). ... and more »

Autoantibodies to BRAF, a new family of autoantibodies associated with ... - 7thSpace Interactive (press release)

Autoantibodies to BRAF, a new family of autoantibodies associated with ... 7thSpace Interactive (press release) We have observed that sera from rheumatoid arthritis (RA) patients recognize the BRAF's catalytic domain, which encompasses amino acids 416 to 766. ...

Allograft Compared with Autograft Infection Rates in Primary Anterior Cruciate ... - Journal of Bone and Joint Surgery (subscription)

Allograft Compared with Autograft Infection Rates in Primary Anterior Cruciate ... Journal of Bone and Joint Surgery (subscription) Exclusion criteria for this study included any known risk factors for surgical site infection 37,38 (diabetes mellitus, rheumatoid arthritis, ... and more »

Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohn's ... - PR Newswire (press release)

Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohn's ... PR Newswire (press release) It is also approved for the treatment of adults with moderately to severely active rheumatoid arthritis. Certolizumab pegol was approved in Switzerland for ... and more »